Rising bond yields are currently acting as a headwind for stocks and valuations, and that leaves investors with one clear ...

Citing advances in autonomous vehicle (AV) technology and embedded artificial intelligence as main drivers, Morgan Stanley ( ...

These 173 leaders will help steer the firm as Wall Street readies for a potential flood of dealmaking, from M&A to IPOs.

Most local bankers received 10 per cent to 15 per cent bonus increases compared to last year, with raises of as much as 50 ...

Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...

Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

While Citi, BofA and Goldman touted their biggest cohorts of managing directors in years, Morgan Stanley elevated greater ...

The bulk of Morgan Stanley's new managing directors, or 46%, work for the investment bank.

Looking ahead, Morgan Stanley expects PB Fintech's stock to de-rate as core new business performance moderates in FY26.

The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...

Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate ...

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US ...